Report
Arnaud Despre ...
  • Mohamed Kaabouni
  • Nicolas Royot
  • Yann de Peyrelongue

La Matinale - 2022-01-14

ESKER : Une guidance trop prudente ? – Conserver (3), obj. 300.0€ Cours: 294.0€ au 13/01/22
ID LOGISTICS : 80M€ de CA 2025 pour Colisweb – Renforcer (2), obj. 370.0€ Cours: 327.0€ au 13/01/22
MITHRA : Premiers résultats de phase III encourageants pour Donesta® – Acheter (1), obj. 40.4€ Cours: 36.5€ au 13/01/22
THERMADOR GROUPE : Thermador, le tube de l'année – Renforcer (2) vs Conserver (3), obj. 104.0€ Cours: 98.5€ au 13/01/22
VICAT* : Avance sur ses solutions très bas carbone Cours: 37.8€ au 13/01/22
ET AUSSI : BELIEVE, LA FRANÇAISE DE L'ENERGIE, MAUNA KEA TECHNOLOGIES…
Underlyings
Esker SA

ESKER and its subsidiaries are engaged in the design and production of software applications. Co. operates corporate resource access software such as applications and databases for workstations. Co. has three major product groups: Host Access, DeliveryWare and Fax Server. Host Access products allows users to access applications and databases stored on different servers from their own workstations. DeliveryWare responds to the need of companies for automatic management document delivery. Fax Server allows the user to send a fax directly from their workstation.

ID Logistics Group

ID Logistics is an international contract logistics group that designs and implements one-stop services tailored to the specific requirements of each client. The services Co. offers combine customized architectures to allow clients to optimize their supply chain.

N.V. Mithra Pharmaceuticals S.A.

Mithra Pharmaceuticals SA is a Belgium-based company active in the pharmaceutical industry. The Company is dedicated to provide products and services for the fertility, contraception and menopause of women. It has a number of patent families regarding Estetrol (E4), a natural estrogen produced by the human foetus, which enables the investigation of fertility and contraception products. Mithra is focused on the development of two late-stage E4-based products: Estelle, a 5th generation oral contraceptive, and Donesta, a hormone therapy for Vasomotor Symptoms in menopause. Mithra develops a contraceptive vaginal ring called Myring and Zoreline, a biodegradable subcutaneous implant for hormone dependant cancer.

Thermador Groupe

Provider
Portzamparc Sponsored
Portzamparc Sponsored

​Portzamparc is a subsidary of BNP Paribas which adapted the mission to contribute to responsible and sustainable growth of private clients, management companies and SMEs . They offer personalized support adapted to the objectives in particular for Small and Medium-Sized Enterprises.

Analysts
Arnaud Despre

Mohamed Kaabouni

Nicolas Royot

Yann de Peyrelongue

Other Reports on these Companies
Other Reports from Portzamparc Sponsored

ResearchPool Subscriptions

Get the most out of your insights

Get in touch